- Home
- RDY vs CAVA Comparison
RDY vs CAVA Comparison
Compare RDY & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- CAVA
- Stock Information
- Founded
- RDY 1984
- CAVA 2006
- Country
- RDY India
- CAVA United States
- Employees
- RDY N/A
- CAVA N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- CAVA Restaurants
- Sector
- RDY Health Care
- CAVA Consumer Discretionary
- Exchange
- RDY Nasdaq
- CAVA Nasdaq
- Market Cap
- RDY 11.8B
- CAVA 10.0B
- IPO Year
- RDY N/A
- CAVA 2023
- Fundamental
- Price
- RDY $14.22
- CAVA $67.55
- Analyst Decision
- RDY Strong Buy
- CAVA Buy
- Analyst Count
- RDY 2
- CAVA 15
- Target Price
- RDY $16.95
- CAVA $102.80
- AVG Volume (30 Days)
- RDY 1.0M
- CAVA 6.3M
- Earning Date
- RDY 07-23-2025
- CAVA 08-12-2025
- Dividend Yield
- RDY 0.50%
- CAVA N/A
- EPS Growth
- RDY 2.20
- CAVA 213.93
- EPS
- RDY 0.79
- CAVA 1.18
- Revenue
- RDY $3,897,394,052.00
- CAVA $1,083,653,000.00
- Revenue This Year
- RDY $7.33
- CAVA $25.04
- Revenue Next Year
- RDY $1.96
- CAVA $21.66
- P/E Ratio
- RDY $18.01
- CAVA $57.28
- Revenue Growth
- RDY 15.86
- CAVA 28.21
- 52 Week Low
- RDY $12.26
- CAVA $65.03
- 52 Week High
- RDY $16.71
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- RDY 46.98
- CAVA 35.08
- Support Level
- RDY $14.08
- CAVA $65.03
- Resistance Level
- RDY $14.59
- CAVA $68.91
- Average True Range (ATR)
- RDY 0.17
- CAVA 2.69
- MACD
- RDY 0.04
- CAVA -0.34
- Stochastic Oscillator
- RDY 44.87
- CAVA 12.52
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.